Skip to main content

October 2016 - FRMC

Featured Article

10/20/2016
Paul Nicolaus
With insurers pulling out, premiums on the rise, and the presidential election on the way, the fate of Obamacare hangs in the balance. 
With insurers pulling out, premiums on the rise, and the presidential election on the way, the fate of Obamacare hangs in the balance. 
With insurers pulling out,...
10/20/2016
First Report Managed Care
News Connection
11/20/2016
A recently published review suggests that alternatives to inpatient hospitalization do not jeopardize the treatment of several acute medical conditions.
A recently published review suggests that alternatives to inpatient hospitalization do not jeopardize the treatment of several acute medical conditions.
A recently published review...
11/20/2016
First Report Managed Care
10/20/2016
Mary Beth Nierengarten
As the popularity of rare-disease indicated orphan drugs increases, payers are becoming concerned about whether or not these prescriptions are entirely necessary.
As the popularity of rare-disease indicated orphan drugs increases, payers are becoming concerned about whether or not these prescriptions are entirely necessary.
As the popularity of...
10/20/2016
First Report Managed Care
10/20/2016
Dean Celia
Recent controversy related to drug price gouging has pushed the issue onto the political stage in the midst of the 2016 Presidential election. Each candidate has taken a stance against allowing drug companies to unnecessarily raise prices to...
Recent controversy related to drug price gouging has pushed the issue onto the political stage in the midst of the 2016 Presidential election. Each candidate has taken a stance against allowing drug companies to unnecessarily raise prices to...
Recent controversy related to...
10/20/2016
First Report Managed Care
News
10/20/2016
Dean Celia
After public backlash against exorbitant price increases for the EpiPen, industry leaders are weighing in on the practicality of the new price and the validity of possible solutions presented by its manufacturer.
After public backlash against exorbitant price increases for the EpiPen, industry leaders are weighing in on the practicality of the new price and the validity of possible solutions presented by its manufacturer.
After public backlash against...
10/20/2016
First Report Managed Care
Managed Care Q&A
10/20/2016
David Costill
An interview with Chad Johnson, senior vice president and executive director, Phoenix Children’s Care Network.
An interview with Chad Johnson, senior vice president and executive director, Phoenix Children’s Care Network.
An interview with Chad...
10/20/2016
First Report Managed Care
News Connection
10/20/2016
A group of Republican lawmakers are urging the Centers for Medicare and Medicaid Services (CMS) to revise its proposed implementation of the Medicare Access and CHIP Reauthorization Act, or MACRA, of 2015, which they argue would complicate...
A group of Republican lawmakers are urging the Centers for Medicare and Medicaid Services (CMS) to revise its proposed implementation of the Medicare Access and CHIP Reauthorization Act, or MACRA, of 2015, which they argue would complicate...
A group of Republican lawmakers...
10/20/2016
First Report Managed Care
News Connection
10/20/2016
An internal investigation by the US Department of Veterans’ Affairs (VA) found that the bloated budget and costly delays for construction of a new VA medical campus near Denver, Colorado were caused by gross mismanagement.
An internal investigation by the US Department of Veterans’ Affairs (VA) found that the bloated budget and costly delays for construction of a new VA medical campus near Denver, Colorado were caused by gross mismanagement.
An internal investigation by the...
10/20/2016
First Report Managed Care
News Connection
10/20/2016
According to recent research, for rheumatoid arthritis patients who have failed initial anti-tumor necrosis factor therapy, care providers should consider a non–TNF-targeted biologic due to a an effictive clinical response.
According to recent research, for rheumatoid arthritis patients who have failed initial anti-tumor necrosis factor therapy, care providers should consider a non–TNF-targeted biologic due to a an effictive clinical response.
According to recent research,...
10/20/2016
First Report Managed Care
News Connection
10/20/2016
Malnutrition associated with disease is responsible for more than $15.5 billion in direct medical costs each year, and is disproportionately driven by patients aged 65 years or older, according to an economic analysis recently published in...
Malnutrition associated with disease is responsible for more than $15.5 billion in direct medical costs each year, and is disproportionately driven by patients aged 65 years or older, according to an economic analysis recently published in...
Malnutrition associated with...
10/20/2016
First Report Managed Care
News Connection
10/20/2016
A recent analysis suggests myocardial infarction patients who were treated in health care institutions that demonstrated favorable 30-day risk-standardized mortality rates, also had longer life expectancies when compared to patients who were...
A recent analysis suggests myocardial infarction patients who were treated in health care institutions that demonstrated favorable 30-day risk-standardized mortality rates, also had longer life expectancies when compared to patients who were...
A recent analysis suggests...
10/20/2016
First Report Managed Care
News Connection
10/20/2016
Approximately 1 in 4 Americans reported worsened medical conditions after postponing an ED visit due to cost and insurance coverage concerns.
Approximately 1 in 4 Americans reported worsened medical conditions after postponing an ED visit due to cost and insurance coverage concerns.
Approximately 1 in 4 Americans...
10/20/2016
First Report Managed Care
News Connection
10/20/2016
The largest US health insurer, Anthem Inc, recently announced it would not cover the first FDA-approved Duchenne muscular dystrophy drug (DMD), Exondys 51 (eteplirsen; Sarepta Therapeutics) due to concerns over clinical trial data.
The largest US health insurer, Anthem Inc, recently announced it would not cover the first FDA-approved Duchenne muscular dystrophy drug (DMD), Exondys 51 (eteplirsen; Sarepta Therapeutics) due to concerns over clinical trial data.
The largest US health insurer,...
10/20/2016
First Report Managed Care
News Connection
10/20/2016
Inpatient drug costs rose 38.7% per admission between 2013 and 2015, according to a new analysis from the National Opinion Research Center at the University of Chicago.
Inpatient drug costs rose 38.7% per admission between 2013 and 2015, according to a new analysis from the National Opinion Research Center at the University of Chicago.
Inpatient drug costs rose 38.7%...
10/20/2016
First Report Managed Care
News Connection
10/20/2016
A recent commentary in The American Journal of Managed Care suggests that policymakers should expand prescription drug monitoring programs to include all medications instead of opiates alone to help reduce outpatient medication errors.
A recent commentary in The American Journal of Managed Care suggests that policymakers should expand prescription drug monitoring programs to include all medications instead of opiates alone to help reduce outpatient medication errors.
A recent commentary in The...
10/20/2016
First Report Managed Care
News Connection
10/20/2016
According to a recent editorial, pressure from a patient or payer often rectifies situations where managed behavioral health care organizations are providing poor psychiatric treatment.
According to a recent editorial, pressure from a patient or payer often rectifies situations where managed behavioral health care organizations are providing poor psychiatric treatment.
According to a recent editorial,...
10/20/2016
First Report Managed Care
Trends Report
10/20/2016
This will serve as part 2 of the 3-part First Report Managed Care Trends Report on autoimmune diseases. This second part will report the findings from survey participants on psoriasis and atopic dermatitis.
This will serve as part 2 of the 3-part First Report Managed Care Trends Report on autoimmune diseases. This second part will report the findings from survey participants on psoriasis and atopic dermatitis.
This will serve as part 2 of the...
10/20/2016
First Report Managed Care
Formulary Frontlines®
10/20/2016
Eileen Koutnik-Fotopoulos; David Costill
According to the CDC, asthma affects approximately 26 million Americans at an incremental cost of $56 billion annually; while Medicaid spends over $10 billion per year treating asthma. Severe asthma caused by poor medication adherence leads...
According to the CDC, asthma affects approximately 26 million Americans at an incremental cost of $56 billion annually; while Medicaid spends over $10 billion per year treating asthma. Severe asthma caused by poor medication adherence leads...
According to the CDC, asthma...
10/20/2016
First Report Managed Care
Department
10/20/2016
An increase in genetic testing expenditures in specialty pharmacy requires improved coverage as utilization and expenditures are expected to grow in the coming years, according to recent research at the 2016 NASP Annual Meeting.
An increase in genetic testing expenditures in specialty pharmacy requires improved coverage as utilization and expenditures are expected to grow in the coming years, according to recent research at the 2016 NASP Annual Meeting.
An increase in genetic testing...
10/20/2016
First Report Managed Care
Department
10/20/2016
Implementation of patient assistance programs and copay assistance programs increased access to specialty medications.
Implementation of patient assistance programs and copay assistance programs increased access to specialty medications.
Implementation of patient...
10/20/2016
First Report Managed Care
Department
10/20/2016
Research showed that use of a “smart pill-bottle,” which provides additional reminders and instructions to patients, increased medication adherence.
Research showed that use of a “smart pill-bottle,” which provides additional reminders and instructions to patients, increased medication adherence.
Research showed that use of a...
10/20/2016
First Report Managed Care
Department
10/20/2016
A coordination program between a specialty pharmacy and specialty clinics helped to promote and improve access to direct acting antiviral therapies for hepatitis C, according to an abstract presented at the 2016 NASP Annual Meeting.
A coordination program between a specialty pharmacy and specialty clinics helped to promote and improve access to direct acting antiviral therapies for hepatitis C, according to an abstract presented at the 2016 NASP Annual Meeting.
A coordination program between a...
10/20/2016
First Report Managed Care
Department
10/20/2016
Recent research presented at the 2016 NASP Annual Meeting found that when out-of-pocket costs are lower and treatment satisfaction is high, patients with multiple sclerosis (MS) are more likely to adhere to disease-modifying drugs.
Recent research presented at the 2016 NASP Annual Meeting found that when out-of-pocket costs are lower and treatment satisfaction is high, patients with multiple sclerosis (MS) are more likely to adhere to disease-modifying drugs.
Recent research presented at the...
10/20/2016
First Report Managed Care